News

NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify'
The National Institute for Health and Care Excellence (NICE) has refused the 'miracle' drugs lecanemab and donanemab for use on the NHS as they are too expensive to justify.
Frontiers3d
Task-shifting in Dementia Care: A comparative analysis of consultation models and proposed collaborative ecosystem in Japan
task-shifting in dementia care has been proposed to meet the needs of persons living with dementia (PLWD). In Japan, the Initial-phase Intensive Support Service (IPIS), led by primary care physicians, ...
The Japan Times3d
Middle— to old-age depression may be tied to dementia
A study has found that abnormal tau protein causing dementia accumulates in the brains of middle— to old-age patients with ...
Large-scale study maps the first step in Alzheimer's protein aggregation
A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...
Controlling This One Molecule Could Halt Alzheimer’s in Its Tracks
New research identifies the immune molecule STING as a driver of brain damage in Alzheimer’s. A new approach to Alzheimer’s ...
Virtual reality could add empathy to dementia care
At a conference on aging two years ago, Li-Mei Chen slipped on a pair of virtual reality (VR) goggles and found herself ...
McKnight's Long-Term Care News6d
New research: MIND diet linked to lower Alzheimer’s risk at any age
A new study confirms that following the MIND diet can reduce Alzheimer's disease risk in older US adults, with researchers ...